Literature DB >> 16857173

Functional characterisation of ganglioside-induced differentiation-associated protein 1 as a glutathione transferase.

Alison J Shield1, Tracy P Murray, Philip G Board.   

Abstract

Mutations in the ganglioside-induced differentiation-associated protein 1 (GDAP1) gene have been linked with Charcot-Marie-Tooth (CMT) disease. This protein, and its paralogue GDAP1L1, appear to be structurally related to the cytosolic glutathione S-transferases (GST) including an N-terminal thioredoxin fold domain with conserved active site residues. The specific function, of GDAP1 remains unknown. To further characterise their structure and function we purified recombinant human GDAP1 and GDAP1L1 proteins using bacterial expression and immobilised metal affinity chromatography. Like other cytosolic GSTs, GDAP1 protein has a dimeric structure. Although the full-length proteins were largely insoluble, the deletion of a proposed C-terminal transmembrane domain allowed the preparation of soluble protein. The purified proteins were assayed for glutathione-dependent activity against a library of 'prototypic' GST substrates. No evidence of glutathione-dependent activity or an ability to bind glutathione immobilised on agarose was found.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16857173     DOI: 10.1016/j.bbrc.2006.06.189

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  L239F founder mutation in GDAP1 is associated with a mild Charcot-Marie-Tooth type 4C4 (CMT4C4) phenotype.

Authors:  Dagmara Kabzińska; Halina Strugalska-Cynowska; Anna Kostera-Pruszczyk; Barbara Ryniewicz; Renata Posmyk; Alina Midro; Pavel Seeman; Lucia Báranková; Magdalena Zimoń; Jonathan Baets; Vincent Timmerman; Velina Guergueltcheva; Ivailo Tournev; Stayko Sarafov; Peter De Jonghe; Albena Jordanova; Irena Hausmanowa-Petrusewicz; Andrzej Kochański
Journal:  Neurogenetics       Date:  2010-03-16       Impact factor: 2.660

Review 2.  S-glutathionyl-(chloro)hydroquinone reductases: a new class of glutathione transferases functioning as oxidoreductases.

Authors:  Sara M Belchik; Luying Xun
Journal:  Drug Metab Rev       Date:  2011-03-22       Impact factor: 4.518

3.  GM1 ganglioside in Parkinson's disease: Pilot study of effects on dopamine transporter binding.

Authors:  Jay S Schneider; Franca Cambi; Stephen M Gollomp; Hiroto Kuwabara; James R Brašić; Benjamin Leiby; Stephanie Sendek; Dean F Wong
Journal:  J Neurol Sci       Date:  2015-06-16       Impact factor: 3.181

4.  Charcot-Marie-Tooth-related gene GDAP1 complements cell cycle delay at G2/M phase in Saccharomyces cerevisiae fis1 gene-defective cells.

Authors:  Anna Estela; David Pla-Martín; Maribel Sánchez-Piris; Hiromi Sesaki; Francesc Palau
Journal:  J Biol Chem       Date:  2011-09-02       Impact factor: 5.157

5.  Mitochondrial complex I deficiency in GDAP1-related autosomal dominant Charcot-Marie-Tooth disease (CMT2K).

Authors:  Julien Cassereau; Arnaud Chevrollier; Naïg Gueguen; Marie-Claire Malinge; Franck Letournel; Guillaume Nicolas; Laurence Richard; Marc Ferre; Christophe Verny; Frédéric Dubas; Vincent Procaccio; Patrizia Amati-Bonneau; Dominique Bonneau; Pascal Reynier
Journal:  Neurogenetics       Date:  2008-12-17       Impact factor: 2.660

6.  A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients.

Authors:  Jay S Schneider; Stephen M Gollomp; Stephanie Sendek; Amy Colcher; Franca Cambi; Wei Du
Journal:  J Neurol Sci       Date:  2012-11-28       Impact factor: 3.181

7.  Dominant GDAP1 mutations cause predominantly mild CMT phenotypes.

Authors:  M Zimoń; J Baets; G M Fabrizi; E Jaakkola; D Kabzińska; J Pilch; A B Schindler; D R Cornblath; K H Fischbeck; M Auer-Grumbach; C Guelly; N Huber; E De Vriendt; V Timmerman; U Suter; I Hausmanowa-Petrusewicz; A Niemann; A Kochański; P De Jonghe; A Jordanova
Journal:  Neurology       Date:  2011-07-13       Impact factor: 9.910

Review 8.  A critical role for GM1 ganglioside in the pathophysiology and potential treatment of Parkinson's disease.

Authors:  J S Schneider
Journal:  Glycoconj J       Date:  2021-05-26       Impact factor: 2.916

9.  A locus-specific database for mutations in GDAP1 allows analysis of genotype-phenotype correlations in Charcot-Marie-Tooth diseases type 4A and 2K.

Authors:  Julien Cassereau; Arnaud Chevrollier; Dominique Bonneau; Christophe Verny; Vincent Procaccio; Pascal Reynier; Marc Ferré
Journal:  Orphanet J Rare Dis       Date:  2011-12-26       Impact factor: 4.123

10.  A structural basis for cellular uptake of GST-fold proteins.

Authors:  Melanie J Morris; Dan Liu; Llara M Weaver; Philip G Board; Marco G Casarotto
Journal:  PLoS One       Date:  2011-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.